Quality, Cost of Care Similar for Allopathic, Osteopathic Hospitalists

TUESDAY, May 30, 2023 (HealthDay News) -- The quality and costs of care are similar for allopathic and osteopathic hospitalists caring for Medicare patients, according to a study published online May 30 in the Annals of Internal Medicine.
Atsushi Miyawaki, M.D., Ph.D., from the David Geffen School of Medicine at UCLA in Los Angeles, and colleagues conducted a retrospective observational study using Medicare claims data to examine whether quality and costs of care differ for hospitalized Medicare patients treated by allopathic or osteopathic physicians. Overall, 329,510 admissions for Medicare fee-for-service beneficiaries hospitalized with a medical condition during 2016 to 2019 were included: 77.0 and 23.0 percent received care from allopathic and osteopathic physicians, respectively.
The researchers observed no important differences in quality and costs of care between allopathic and osteopathic physicians for patient mortality (adjusted mortality, 9.4 versus 9.5 percent), readmission (15.7 versus 15.6 percent), length of stay (4.5 versus 4.5 days), and health care spending ($1,004 versus $1,003).
"These findings should be reassuring for policymakers, medical educators, and patients because they suggest that any differences between allopathic and osteopathic medical schools, either in terms of educational approach or students who enroll, are not associated with differences in quality or costs of care, at least in the inpatient setting," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Related Posts
A-Fib May Be Bigger Threat to Women’s Brains Than Men’s
MONDAY, June 26, 2023 (HealthDay News) -- A new study finds that women with a...
Health Highlights: Dec. 13, 2021
First real-world studies into vaccine effectiveness against Omicron. The ability...
Drug Choice Might Matter for Patients With Macular Degeneration
WEDNESDAY, Dec. 7, 2022 (HealthDay News) -- One of the two most common drugs...
Un marcador de una prueba sanguínea podría medir los riesgos tras la cirugía cardiaca
JUEVES, 3 de marzo de 2022 (HealthDay News) -- Cada año, alrededor de 2 millones...